Todd Blanche pledges to use the DOJ to stop the mailing of abortion pill
Blanche agrees in his confirmation hearing to review using the 1873 Comstock Act to stop mifepristone from being sent to pregnant women by mail
By Bonnie Fuller - July 20, 2026
Blanche agrees in his confirmation hearing to review using the 1873 Comstock Act to stop mifepristone from being sent to pregnant women by mail
By Bonnie Fuller - July 20, 2026
Three attorneys general argue federal laws around the mifepristone make it difficult for states to enforce abortion bans
By Anna Spoerre, Missouri Independent - October 22, 2024
The Louisiana Legislature gave final approval Thursday to a bill that would label two drugs used to induce labor and treat miscarriages as “controlled dangerous substances,” despite opposition from a broad group of medical professionals.
By Greg LaRose, Louisiana Illuminator - May 24, 2024
And a future case centered on the Comstock Act is building, too
By Charlotte Rene Woods, Virginia Mercury - May 24, 2024
Donald Trump is planning to release more details in the weeks ahead about how his administration would regulate access to medication abortion, according to comments he made during a lengthy interview with Time magazine published Tuesday.
By Jennifer Shutt, States Newsroom - April 30, 2024
Minnesota lawmakers last year passed a sweeping law protecting abortion rights and making Minnesota a reproductive rights refuge in the Upper Midwest. But the U.S. Supreme Court is considering a case whose outcome could still limit access to an abortion pill despite Minnesota’s protections.
By Michelle Griffith, Minnesota Reformer - March 25, 2024
The latest news impacting reproductive rights around the country.
By Rebekah Sager - August 18, 2023
Aid Access partners with abortion providers who can prescribe abortion medication to anyone who needs it, including users in restricted states.
By Rebekah Sager - August 01, 2023
Plan C has been a resource for those seeking abortion medication information online since before Roe v. Wade was overturned.
By Rebekah Sager - July 11, 2023
Since the fall of Roe v. Wade in 2022, cases for and against bans on abortion continue to be heard in courtrooms across the nation.
By Rebekah Sager - April 26, 2023
A new poll found that a nationwide ban on the drug mifepristone is overwhelmingly unpopular — including among Republicans.
By Emily Singer - April 24, 2023
With some of the highest maternal death rates in the nation, Black pregnant people face extreme impacts on their health, particularly those in states with restrictive abortion bans.
By Rebekah Sager - April 17, 2023
The new limits to the abortion pill's use will take effect Saturday unless the court acts before then.
By Associated Press - April 14, 2023
The ruling by the 5th Circuit Court of Appeals late Wednesday blocked FDA changes from 2016 allowing the abortion pill mifepristone to be delivered by mail.
By Associated Press - April 13, 2023
Judge Matthew Kacsmaryk once referred to marriage equality advocates as ‘sexual revolutionaries,’ and even Susan Collins wouldn’t vote for him.
By Will Fritz - April 12, 2023
Officials in Washington, California, New York and Massachusetts have announced purchases of mifepristone and misoprostol.
By Rebekah Sager - April 11, 2023
The Department of Justice appealed a federal judge’s ruling that the FDA had illegally approved mifepristone 23 years ago.
By Rebekah Sager - April 11, 2023
Anti-abortion lawmakers have increasingly tried to normalize a practice in recent years that most medical professionals deem unethical and non-scientific.
By Rebekah Sager - March 23, 2023
An anti-abortion group is seeking to reverse the FDA’s approval of mifepristone, which could result in the pill being removed from the market across the country.
By Associated Press - March 15, 2023
Patients who are miscarrying face so much ‘chaos and fear’ as states tighten abortion restrictions, Sen. Mazie Hirono said in urging Danco Laboratories to petition the FDA for the change.
By 19th News - February 07, 2023Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution 4.0 International License .